180 related articles for article (PubMed ID: 8244261)
1. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators.
Donaldson BW; Gopinath R; Wanless IR; Phillips MJ; Cameron R; Roberts EA; Greig PD; Levy G; Blendis LM
Hepatology; 1993 Dec; 18(6):1370-6. PubMed ID: 8244261
[TBL] [Abstract][Full Text] [Related]
2. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
[TBL] [Abstract][Full Text] [Related]
3. Liver histology as predictor of outcome in patients with acute liver failure.
Singhal A; Vadlamudi S; Stokes K; Cassidy FP; Corn A; Shrago SS; Wright HI; Kohli V
Transpl Int; 2012 Jun; 25(6):658-62. PubMed ID: 22487361
[TBL] [Abstract][Full Text] [Related]
4. Histopathological heterogeneity in fulminant hepatic failure.
Hanau C; Munoz SJ; Rubin R
Hepatology; 1995 Feb; 21(2):345-51. PubMed ID: 7843704
[TBL] [Abstract][Full Text] [Related]
5. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study.
Chenard-Neu MP; Boudjema K; Bernuau J; Degott C; Belghiti J; Cherqui D; Costes V; Domergue J; Durand F; Erhard J; De Hemptinne B; Gubernatis G; Hadengue A; Kemnitz J; McCarthy M; Maschek H; Mentha G; Oldhafer K; Portmann B; Praet M; Ringers J; Rogiers X; Rubbia L; Schalm S; Bellocq JP
Hepatology; 1996 May; 23(5):1119-27. PubMed ID: 8621143
[TBL] [Abstract][Full Text] [Related]
6. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage.
Gazzard BG; Portmann B; Murray-Lyon IM; Williams R
Q J Med; 1975 Oct; 44(176):615-26. PubMed ID: 172938
[TBL] [Abstract][Full Text] [Related]
7. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure.
Schiødt FV; Bondesen S; Petersen I; Dalhoff K; Ott P; Tygstrup N
Hepatology; 1996 Apr; 23(4):713-8. PubMed ID: 8666322
[TBL] [Abstract][Full Text] [Related]
8. Contribution of transjugular liver biopsy in patients with the clinical presentation of acute liver failure.
Miraglia R; Luca A; Gruttadauria S; Minervini MI; Vizzini G; Arcadipane A; Gridelli B
Cardiovasc Intervent Radiol; 2006; 29(6):1008-10. PubMed ID: 16967214
[TBL] [Abstract][Full Text] [Related]
9. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure.
Yantorno SE; Kremers WK; Ruf AE; Trentadue JJ; Podestá LG; Villamil FG
Liver Transpl; 2007 Jun; 13(6):822-8. PubMed ID: 17539002
[TBL] [Abstract][Full Text] [Related]
10. Transjugular liver biopsy using Tru-cut biopsy needle: KEM experience.
Rathod K; Deshmukh H; Nihal L; Basappa S; Rathi P; Bhatia S
J Assoc Physicians India; 2008 Jun; 56():425-8. PubMed ID: 18822621
[TBL] [Abstract][Full Text] [Related]
11. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with contraindications to ordinary percutaneous liver biopsy and an "in-house" protocol for selecting the procedure of choice.
Atar E; Ben Ari Z; Bachar GN; Amlinski Y; Neyman C; Knizhnik M; Litvin S; Schmilovitz-Weiss H; Shapiro R; Bruckhaimer E; Tur-Kaspa R; Belenky A
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):560-4. PubMed ID: 19908088
[TBL] [Abstract][Full Text] [Related]
12. Prognostic indicators in fulminant hepatic failure.
Frohburg E; Stölzel U; Lenz K; Schäfer JH; Tung LC; Riecken EO
Z Gastroenterol; 1992 Sep; 30(9):571-5. PubMed ID: 1449004
[TBL] [Abstract][Full Text] [Related]
13. Transjugular liver biopsy in patients with diffuse liver disease: comparison of three cores with one or two cores for accurate histological interpretation.
Cholongitas E; Quaglia A; Samonakis D; Mela M; Patch D; Dhillon AP; Fanshawe TR; Burroughs AK
Liver Int; 2007 Jun; 27(5):646-53. PubMed ID: 17498250
[TBL] [Abstract][Full Text] [Related]
14. Transjugular renal biopsy: our experience and technical considerations.
See TC; Thompson BC; Howie AJ; Karamshi M; Papadopoulou AM; Davies N; Tibballs J
Cardiovasc Intervent Radiol; 2008; 31(5):906-18. PubMed ID: 18266029
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.
Hadem J; Stiefel P; Bahr MJ; Tillmann HL; Rifai K; Klempnauer J; Wedemeyer H; Manns MP; Schneider AS
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):339-45. PubMed ID: 18328438
[TBL] [Abstract][Full Text] [Related]
16. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.
Hassoun Z; Shah V; Lohse CM; Pankratz VS; Petrovic LM
Liver Transpl; 2004 Apr; 10(4):480-7. PubMed ID: 15048789
[TBL] [Abstract][Full Text] [Related]
17. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y
Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in paediatric acute liver failure.
Ciocca M; Ramonet M; Cuarterolo M; López S; Cernadas C; Alvarez F
Arch Dis Child; 2008 Jan; 93(1):48-51. PubMed ID: 17872939
[TBL] [Abstract][Full Text] [Related]
19. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
20. [Transjugular liver biopsy: retrospective study performed on 71 patients].
Quevedo E; Tan J; Araujo G; Morales H; Távara F
Rev Gastroenterol Peru; 2003; 23(4):254-8. PubMed ID: 14716419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
